Tracked deals
20
20 tracked deals across 2019-2026.
Tracked deals
20
20 tracked deals across 2019-2026.
Buyer mix
Strategic-led
15 strategic · 8 pe
Top trend
Volume peaked in 2021
7 tracked deals announced in 2021.
Primary Insight
Build a buyer list for your Medical Devices deal
Find buyers actively acquiring medical devices companies.
Find buyers like these for your dealBuyer Snapshot
Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.
| Buyer | # Deals | Focus | Type |
|---|---|---|---|
| ADDvise Group AB | 1 | Swedish listed supplier of equipment and solutions to hea... | Strategic |
| ARCHIMED | 1 | Healthcare-focused private equity firm investing in MedTe... | PE |
| American Industrial Partners (AIP) | 1 | Operationally oriented industrials investor that makes co... | PE |
| Atlantic Street Capital | 1 | Private equity firm investing in lower middle market comp... | PE |
| Branford Castle Partners | 1 | Middle‑market private equity firm making control investme... | PE |
| CenterGate Capital | 1 | Austin-based private equity firm focused on lower middle ... | PE |
| ClariMed, Inc. | 1 | Provider of human-centered medical device development, hu... | Strategic |
| DJO (a subsidiary of Colfax Corporation) | 1 | Global developer and distributor of medical technologies ... | Strategic |
| DuPont de Nemours, Inc. | 1 | Global materials science and specialty chemicals company ... | Strategic |
| Hilco Vision | 1 | Global eye care company and distributor combining multipl... | Strategic (PE-backed) |
Last 7 years
Supporting Data
Avanos Medical has entered into a definitive agreement to be acquired by affiliates of American Industrial Partners (AIP) in an all-cash transaction valued at approximately $1.272 billion. Avanos stockholders will receive $25.00 per share, representing a premium of about 72.1% to the April 13, 2026 closing price, and the deal is expected to close in the second half of 2026 subject to customary approvals and regulatory clearances.
Tactile Systems Technology (doing business as Tactile Medical) acquired LymphaTech, Inc. for an upfront cash payment of $6.8 million plus potential milestone-based consideration to expand its lymphedema solutions into digital and connected care. LymphaTech co-founders joined Tactile to support commercial adoption and R&D as Tactile integrates the company’s 3D measurement and monitoring platform into its portfolio.
Safe Life, a Sweden-based group focused on life-saving equipment, has acquired AED Brands, an Atlanta-area (Kennesaw, Georgia) distributor of automated external defibrillators, consumables and AED readiness services. The deal expands Safe Life's U.S. footprint and capabilities in AED sales and program services while preserving AED Brands' team and brand.
ClariMed, a human-centered medical device development and regulatory services firm, has acquired We Are Human, a UK/US consultancy specializing in human factors, UX research, and usability testing. The deal brings We Are Human’s team and an Atlanta-based research lab into ClariMed, expanding the buyer’s capabilities and establishing its first Southeast U.S. location.
CenterGate Capital, an Austin-based private equity firm, has acquired The Marena Group, a Lawrenceville, Georgia-based manufacturer of medical-grade compression garments, from The Riverside Company. CenterGate said the investment will provide capital and strategic resources to support Marena's next phase of growth while Marena's CEO Dale Clendon will remain in place.
ARCHIMED, a healthcare-focused private equity firm, has acquired Irrimax Corporation, the Lawrenceville, Georgia-based developer of the Irrisept antimicrobial wound lavage system, through its MED Platform II fund. The partnership aims to scale Irrimax's product range, expand its market presence and accelerate global commercial reach; financial terms were not disclosed.
Stryker has signed a definitive agreement to acquire all issued and outstanding shares of Artelon, a privately held developer of soft tissue fixation products for foot & ankle and sports medicine procedures. The deal adds Artelon's synthetic biomaterial technology and product portfolio (with over 60,000 implantations worldwide) to Stryker's foot & ankle and sports medicine offerings and is subject to customary closing conditions.
Veranex has acquired T3 Labs, a preclinical laboratory based in Atlanta, Georgia. The acquisition expands Veranex's preclinical footprint in North America and deepens its medical‑device testing and therapeutic expertise to provide more integrated services to medtech clients.
DuPont de Nemours, Inc. agreed to acquire Spectrum Plastics Group from AEA Investors in a definitive buyout expected to close in Q3 2023; the purchase is funded from DuPont's existing cash balances. Spectrum is a contract design and advanced manufacturer of specialty medical devices and components (serving top medical device OEMs) and will expand DuPont's healthcare and medical-device materials and manufacturing capabilities.
SunMed (doing business as AirLife) agreed to acquire Avanos Medical's Respiratory Health business, including the BALLARD, MICROCUFF and endOclear brands and two manufacturing facilities in Mexico. The deal (announced June 8, 2023 and completed Oct 2023) expands SunMed's anesthesia and respiratory consumables portfolio and transfers related R&D and manufacturing capabilities from Avanos as part of Avanos' broader transformation.
UFP Technologies, Inc. (Nasdaq: UFPT) has acquired DAS Medical, Inc., a contract manufacturer of single‑use surgical equipment covers, robotic draping systems and fluid control pouches. The acquisition expands UFP's MedTech capabilities—adding thin film converting and near‑shore manufacturing in the Dominican Republic—and provides additional low‑cost manufacturing options for shared customers.
ADDvise Group AB (publ) has completed the acquisition of all shares in Southern Life Systems, Inc. (SLS). The purchase price is approximately USD 11.0 million (USD 7.6m initial cash consideration plus potential earn-outs), financed with ADDvise's own funds; SLS reported about USD 11.56 million revenue and ~USD 1.68 million adjusted EBITDA for 2020.
Zomedica Corp. acquired Pulse Veterinary Technologies (PulseVet) from Branford Castle Partners for $70.9 million in an all-cash transaction. PulseVet, an Alpharetta, Georgia-based manufacturer of veterinary shock wave therapy systems, expands Zomedica's device portfolio and adds companion-animal and equine treatment capabilities.
Hilco Vision, a portfolio company of Windjammer Capital Investors, has acquired Bruder Healthcare effective September 17, 2021; terms were not disclosed. Bruder, a maker of therapeutic and ophthalmic dry-eye products based in Alpharetta, Georgia, will be integrated into Hilco’s product portfolio as the transaction represents a PE-backed add-on to expand Hilco’s offerings to eye care professionals and consumers.
Atlantic Street Capital has partnered with Renew Digital, a provider of certified pre-owned dental imaging equipment and related service/support, to support the company's growth and expand its field service, warranty and specialty offerings. Renew Digital, founded in 2010 and headquartered outside Atlanta in Norcross, Georgia, will leverage ASC's operational expertise to invest in new markets and accelerate growth.
Summa Equity Fund II has acquired a majority stake in Axion BioSystems, a US life science tools company that develops MEA (microelectrode array) and impedance-based bioelectronic assay technologies. Summa plans to support Axion's commercial scale-up and global growth to accelerate adoption of its platforms across academia and biopharma, particularly in cell and gene therapy and drug discovery applications.
DJO, a subsidiary of Colfax Corporation, has completed the acquisition of MedShape, Inc., a privately held orthopedic medical device company that develops foot and ankle surgical solutions using patented NiTiNOL shape‑memory biomaterials. The deal expands DJO’s reconstructive/foot & ankle portfolio—adding MedShape’s DynaNail TTC Fusion System and other shape‑memory technologies to support improved clinical outcomes.
Teleflex Medical OEM LLC, a subsidiary of Teleflex Incorporated, has acquired IWG High Performance Conductors, Inc.'s medical devices business unit in Trenton, Georgia from an affiliate of International Wire Group, Inc. The acquisition adds minimally invasive medical solutions and engineered medical components to Teleflex's product portfolio and enables IWG to focus on its core wire product divisions.
Branford Castle Partners, a New York‑based private equity firm, has acquired Pulse Veterinary Technologies, LLC, a leading maker of shock wave therapy devices for equine and small‑animal veterinary markets, from Thompson Street Capital Partners. Siguler Guff provided debt financing and made an equity co‑investment; Branford plans to use the platform to accelerate geographic and customer expansion and pursue potential add‑ons.
Noritsu America Corporation has acquired R & F Imaging Inc., a regional medical imaging device sales and service company based in Atlanta, Georgia. Noritsu plans to expand the operation nationwide and retain R & F's owner Rex Fortenberry to support the combined business, leveraging Noritsu's national service footprint and R & F's device expertise.
Full Export
Get the full acquisitions list for this page as CSV + XLSX.
Find buyers actively acquiring medical devices companies.
Recurring names in the page include Hilco Vision, Windjammer Capital Investors, SunMed (SunMed Group Holdings, LLC / AirLife), UFP Technologies, Inc., American Industrial Partners (AIP) affiliates, Tactile Systems Technology (Tactile Medical), ADDvise Group AB, and Zomedica Corp.
The acquisitions highlight capability expansion such as lymphedema digital/connected solutions, human factors/UX research, antimicrobial wound lavage technology, preclinical laboratory services, and contract manufacturing (including single-use surgical equipment components).
Both. Some deals expand product portfolios and brands (e.g., AED distribution/services and medical device platforms), while others add services and testing capabilities (e.g., preclinical lab expansion and regulatory/human-centered development support).
Many entries describe deal structure—such as all-cash buyouts, upfront cash plus potential milestones, or undisclosed financial terms (notably for some private transactions). Pricing specifics vary by deal.